BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 18, 2003
View Archived Issues
Alteon's ALT-711 Phase II Misses; Confirmatory Trial Being Planned
Read More
Roche Scientists Find Pill That Manages Insulin, Blood Sugar In Pancreatic Islets, Liver GK Cells
Read More
Tercica Reels In $44M In Series B Funding For IGF-1 Product Launch
Read More
PPD Expands Into Device Sector, Spins Off Functional Genomics
Read More
Other News To Note
Read More
Clarification
Read More
ArQule Plans $25M Acquisition Of Cyclis To Build R&D Program
Through its planned $25 million purchase of Cyclis Pharmaceuticals Inc., ArQule Inc. will combine a biology-based program with its chemistry-focused technology to build its own research and development business. (BioWorld Today)
Read More